Adaptimmune Therapeutics plc American Depositary Shares | ADAP

Adaptimmune Therapeutics plc American Depositary Shares Profile

  • Sector: Health Technology
  • Industry: Biotechnology
  • Employees: 462

Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Adaptimmune Therapeutics plc American Depositary Shares in the news

Services We Offer

Need a custom stock scraper? Want to do some machine learning? We are here to help! Reach out to us!

Machine Learning

Custom Scraper

Automation

Consulting